Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications ; day:18 ; month:3 ; year:2024 ; pages:1-8
Cancer gene therapy ; (18.3.2024), 1-8
- Urheber
-
Safri, Fatema
Nguyen, Romario
Zerehpooshnesfchi, Shadi
George, Jacob
Qiao, Liang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41417-024-00764-w
- URN
-
urn:nbn:de:101:1-2405210839011.575531748841
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Safri, Fatema
- Nguyen, Romario
- Zerehpooshnesfchi, Shadi
- George, Jacob
- Qiao, Liang
- SpringerLink (Online service)
Ähnliche Objekte (12)
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Mechanisms of chemotherapy resistance in hepatocellular carcinoma
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
Potential prognostic biomarker SERPINA12: implications for hepatocellular carcinoma
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications
Hepatocellular Carcinoma
Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects
Chip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue
Berberine Protects against Hepatocellular Carcinoma Progression by Regulating Intrahepatic T Cell Heterogeneity
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Mechanisms of chemotherapy resistance in hepatocellular carcinoma
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
Potential prognostic biomarker SERPINA12: implications for hepatocellular carcinoma
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications
Hepatocellular Carcinoma
Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects
Chip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue
Berberine Protects against Hepatocellular Carcinoma Progression by Regulating Intrahepatic T Cell Heterogeneity
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Mechanisms of chemotherapy resistance in hepatocellular carcinoma
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
Potential prognostic biomarker SERPINA12: implications for hepatocellular carcinoma
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications
Hepatocellular Carcinoma
Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects
Chip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue